Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983863 · ClinicalTrials.gov registry record
Mapping Institutional Identities and the Production of Ethics
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 61
- Enrollment target
NCT03983863 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 61 participants.
The verdict
NCT03983863 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Background: Researchers want to learn how members of IRB committees interact with each other. They want to see how this affects the decision-making process. They want to learn how members see their role and the roles of their fellow members. They want to see if these views are actualized during meetings. To do this, researchers will sit in on IRB meetings and interview committee members. Objective: To explore the dynamics between IRB members. To explore how these dynamics affect the IRB process of decision making. Eligibility: NIH IRB staff or members Design: In Phase I, an investigator (AI) will sit in on IRB meetings for 6 months. The AI will take notes on the dynamics of the committees. The AI s will focus will be on the dialogue and the behavior of both the group and each member. The AI will also focus on the factors that form the decision-making process. The AI will audio-record the meetings to help take detailed notes. These recordings will be destroyed after 3 months. If the AI does not hear from members before the IRB meetings, the AI will assume that the member is agreeing to take part in Phase I. In Phase II, the AI will contact some members about taking part in a 60-minute interview. The interview will be semi-structured. It will be on site and in person. It will explore how the members see their role and the roles of others on the committee. Contact information will be collected only for members who take part in Phase II. Data will be de-identified. Withdrawing from the study will not affect any member s role on the IRB.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2021-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03983863
The ClinicalTrials.gov registry entry for NCT03983863 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03983863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03983863 about?
NCT03983863 is a clinical study titled "Mapping Institutional Identities and the Production of Ethics". Background: Researchers want to learn how members of IRB committees interact with each other. They want to see how this affects the decision-making process. They want to learn how members see their role and the roles of their fellow members. They want to see if these views are actualized during mee...
What is the current status of trial NCT03983863?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2019-05-30. Estimated completion is 2021-04-30.
Who is sponsoring clinical trial NCT03983863?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.